Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adults.
Yara YakoubFernando González-OrtizNicholas James AshtonChristine DéryCherie Strikwerda-BrownFrédéric St-OngeValentin OurryMichael SchöllMaiya R GeddesSimon DucharmeMaxime MontembeaultPedro Rosa-NetoJean-Paul SoucyJohn C S BreitnerHenrik ZetterbergKaj BlennowJudes PoirierSylvia Villeneuvenull nullPublished in: medRxiv : the preprint server for health sciences (2024)
Elevated plasma p-tau217 levels in CU individuals strongly indicate future clinical progression.